Use of mycophenolate mofetil for the treatment of fibrotic hypersensitivity pneumonitis
The American Journal of the Medical Sciences · 2025
DOI: 10.1016/j.amjms.2024.07.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of the Medical Sciences, 2025. Verfasst von Ana Casal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonology Department. Clinical-University Hospital of Santiago de Compostela. Santiago de Compostela, Spain. Electronic address: ana.casal.mourino@…. Hauptthemen laut MEDLINE: Mycophenolic Acid, Alveolitis, Extrinsic Allergic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: The optimal treatment of fibrosing hypersensitivity pneumonitis (fHP) is not well understood. The aim of the study was to obtain information about the usefulness of mycophenolate mofetil (MMF) in its treatment. MATERIAL AND METHODS: Quasi-experimental analysis of patients diagnosed with fHP and treated with MMF for one year, in a single centre. From the start of treatment, data collection was prospective. RESULTS: 73 were included and 58 completed the study. FVC% and DLCO% decreased until starting MMF (year -1 to year 0). After completion of treatment (year 1), FVC% stabilised (p=0.336) and DLCO% improved significantly (p=0.004) compared to year 0. Dyspnoea, number of patients without corticosteroids and mean corticosteroid dose also improved significantly (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pulmonology Department. Clinical-University Hospital of Santiago de Compostela. Santiago de Compostela, Spain. Electronic address: ana.casal.mourino@sergas.es.
- Pulmonology Department. Clinical-University Hospital of Santiago de Compostela. Santiago de Compostela, Spain.
- Concepción Arenal Primary Care Center, Santiago de Compostela, Spain; Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain; Department of Medicine, Faculty of Medicine, University of…
- Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain; ISCIII Support Platforms for Clinical Research, Spain.
- Esteveteijin Company, Spain.
- Pulmonology Department. Clinical-University Hospital of Santiago de Compostela. Santiago de Compostela, Spain; Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain; Department of Med…
Zitieren
APA
Casal, A., Suárez-Antelo, J., Gude, F., Lado-Baleato, Ó., Otero, B., Toubes, M. E., Ferreiro, L., Rodríguez-Núñez, N., & Valdés, L. (2025). Use of mycophenolate mofetil for the treatment of fibrotic hypersensitivity pneumonitis. The American Journal of the Medical Sciences. https://doi.org/10.1016/j.amjms.2024.07.021
Vancouver
Casal A, Suárez-Antelo J, Gude F, Lado-Baleato Ó, Otero B, Toubes ME, et al. Use of mycophenolate mofetil for the treatment of fibrotic hypersensitivity pneumonitis. The American Journal of the Medical Sciences. 2025. doi:10.1016/j.amjms.2024.07.021
BibTeX
@article{Casal2025,
author = {Casal, Ana and Suárez-Antelo, Juan and Gude, Francisco and Lado-Baleato, Óscar and Otero, Borja and Toubes, María E and Ferreiro, Lucía and Rodríguez-Núñez, Nuria and Valdés, Luis},
title = {Use of mycophenolate mofetil for the treatment of fibrotic hypersensitivity pneumonitis},
journal = {The American Journal of the Medical Sciences},
year = {2025},
doi = {10.1016/j.amjms.2024.07.021}
}
EUVIMED